DLB - Company ID 0001308547
The table below shows Dolby Laboratories, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $701.89M | $482.05M | $745.36M | $620.13M | $1.23B | $1.07B |
| Short-term investments | $703.00K | $0.00 | $139.15M | $189.21M | $38.84M | $46.95M |
| Receivables | $331.10M | $315.46M | $262.25M | $243.59M | $232.61M | $180.34M |
| Inventory | $30.42M | $33.73M | $35.62M | $23.55M | $10.96M | $25.55M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.39B |
| $1.19B |
| $1.49B |
| $1.31B |
| $1.76B |
| $1.55B |
| Property, plant & equipment | $470.61M | $479.11M | $481.58M | $513.48M | $534.38M | $541.96M |
| Goodwill | $529.90M | $533.21M | $408.41M | $365.15M | $340.69M | $336.94M |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B |
| Accounts payable | $17.84M | $17.38M | $20.93M | $14.17M | $17.78M | $12.62M |
| Total current liabilities | $437.79M | $417.84M | $422.23M | $277.52M | $315.72M | $267.11M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $595.81M | $623.03M | $607.58M | $438.53M | $501.45M | $478.92M |
| Retained earnings | $2.63B | $2.50B | $2.39B | $2.30B | $2.61B | $2.44B |
| Total equity | $2.62B | $2.48B | $2.36B | $2.25B | $2.60B | $2.43B |